MedPath

Optimizing the Management of Postpartum Urinary Retention

Not Applicable
Terminated
Conditions
Urinary Retention
Interventions
Other: Duration of Indwelling Catheter
Registration Number
NCT04187365
Lead Sponsor
Northwestern University
Brief Summary

A study aimed at characterizing the comparing duration of catheterization for treatment of postpartum urinary retention (PUR) and characterizing short and long-term pelvic floor symptoms in women who have PUR.

Detailed Description

The purpose of the study is to compare clinical outcomes of women with bladder distension injuries due to postpartum urinary retention (PUR) who have varying duration of catheterization for initial treatment of postpartum urinary retention.

Hypotheses

1. Longer duration of therapeutic catheterization will be associated with resolution of postpartum voiding dysfunction in women who sustain severe bladder distension injuries due to postpartum urinary retention.

Definition of resolution of postpartum voiding dysfunction:

A. A post void residual volume of less than half of initial instilled volume on the first retrograde voiding trial, AND B. No need for re-treatment for urinary retention within 1 week

2. The incidence of postpartum urinary retention (PUR) will vary by route of delivery, with operative vaginal delivery having the highest incidence.

3. Risk factors for PUR will be related to intrapartum and delivery conditions

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
70
Inclusion Criteria
  1. Age greater than or equal to 18.
  2. Vaginal or cesarean delivery at term (37 weeks gestational age or later) of live-born infants.
  3. English or Spanish speaking and reading.
Read More
Exclusion Criteria
  1. Adults unable to consent.
  2. Women under the age of 18.
  3. Women who are currently pregnant (All women in the study will have already delivered).
  4. Prisoners or detained individuals.
  5. Women who chronically use a urinary catheter for another medical condition.
  6. Women with a neurological disease with bladder manifestations (examples: Cerebrovascular accidents, Multiple sclerosis, Parkinson disease, cerebral palsy).
  7. Women with preeclampsia requiring magnesium treatment for seizure prevention.
  8. Women with prior PUR
  9. Women on anticholinergic medications.
  10. Women who are actively being treated for a UTI.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
GROUP 2 (Severe PUR)Duration of Indwelling CatheterWomen in GROUP 2 will be a randomized to either 3 or 7 days of indwelling catheterization.
Primary Outcome Measures
NameTimeMethod
To evaluate whether 3 days of indwelling catheterization is inferior to 7 days in resolving postpartum urinary retention.1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Northwestern Medicine

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath